Takeda Pharmaceutical Company Limited
CELL PRODUCTION METHOD

Last updated:

Abstract:

An object of the present invention is to provide a novel approach that enables definitive endoderm cells or insulin-producing cells to be efficiently induced and/or manufactured from pluripotent stem cells. The present invention provides a method for producing definitive endoderm cells from pluripotent stem cells, comprising subjecting pluripotent stem cells to first culture in a differentiation-inducing medium in which insulin acts and subsequently to second culture in a differentiation-inducing medium in which insulin does not act.

Status:
Application
Type:

Utility

Filling date:

2 Aug 2019

Issue date:

23 Sep 2021